Stephen Gordon - 20 Feb 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Chief Financial Officer
Signature
By: /s/ Stephen Gordon
Issuer symbol
TMDX
Transactions as of
20 Feb 2023
Transactions value $
$0
Form type
4
Filing time
22 Feb 2023, 19:00:19
Previous filing
03 Feb 2023
Next filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Award $0 +13.1K +228.82% $0.00 18.8K 20 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +20K $0.00 20K 20 Feb 2023 Common Stock 20K $66.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service.